Patent application number | Description | Published |
20100209934 | METHOD OF IDENTIFYING AGENTS WHICH MODULATE THE ACTIVITY OF CALCIUM-ACTIVATED CHLORIDE CHANNEL - The present invention provides a method of identifying an agent which modulates an activity of a protein, wherein the protein is represented by the amino acid sequence of SEQ ID NO: 1 or has at least 90% amino acid sequence identity to SEQ ID NO: 1 and transports chloride ions across a cell membrane, comprising: (a) exposing cells which express the protein to the agent; and (b) measuring degree of chloride ion transport in the exposed cells, wherein a change in the degree of chloride ion transport compared to control cells, which express the protein but not exposed to the agent, is indicative of an agent capable of modulating an activity of the protein. The agents identified by this method can be used for the prevention or treatment of various diseases caused by the dysfunction of calcium activated chloride channel. | 08-19-2010 |
20110224166 | COMPOSITION FOR ACTIVATING MITOCHONDRIA (As Amended) - The present invention relates to a composition for activating mitochondria which contains a chitooligosaccharide as an active constituent. The chitooligosaccharide can increase the activity of mitochondrial enzymes and increase the amount of mitochondrial DNA, and thus it can be suitably used as an active constituent in the composition for activating mitochondria. | 09-15-2011 |
20120129803 | COMPOSITION CONTAINING CHITOOLIGOSACCHARIDE FOR RECOVERING FROM FATIGUE - Disclosed is an anti-fatigue composition containing chitooligosaccharide as an active ingredient. The composition exhibits a fatigue recovery effect, and thus can be widely used in the health food or medical field. | 05-24-2012 |
20120237625 | METABOLISM ACCELERATING COMPOSITION COMPRISING ASTRAGALI RADIX EXTRACT - The present invention provides a composition comprising | 09-20-2012 |
20120289714 | METHOD FOR PREPARING COUMESTROL AND COUMESTROL PREPARED BY SAME - The present invention relates to a method for preparing coumestrol, comprising a step in which beans are germinated and a step in which the beans are fermented, and to coumestrol prepared by the method. | 11-15-2012 |
20130017280 | COMPOSITION FOR ACCELERATING CHANGE IN MUSCLE TYPEAANM Cho; Si YoungAACI SeoulAACO KRAAGP Cho; Si Young Seoul KRAANM Lee; Ji HaeAACI Gyeonggi-doAACO KRAAGP Lee; Ji Hae Gyeonggi-do KRAANM Bae; Il HongAACI Gyeonggi-doAACO KRAAGP Bae; Il Hong Gyeonggi-do KRAANM Song; Min JeongAACI Gyeonggi-doAACO KRAAGP Song; Min Jeong Gyeonggi-do KRAANM Yeo; Hyeon JuAACI SeoulAACO KRAAGP Yeo; Hyeon Ju Seoul KRAANM Seo; Dae BangAACI Gyeonggi-doAACO KRAAGP Seo; Dae Bang Gyeonggi-do KRAANM Kim; Wan GiAACI Gyeonggi-doAACO KRAAGP Kim; Wan Gi Gyeonggi-do KRAANM Lee; Sang JunAACI Gyeonggi-doAACO KRAAGP Lee; Sang Jun Gyeonggi-do KR - The present invention provides a composition for accelerating a change in muscle type, increasing the amount of muscle, strengthening muscle, enhancing athletic abilities, reducing lipids, suppressing the accumulation of lipids, lowering blood sugar, controlling body weight or lowering body weight, containing a PPAR-δ promoter, an AMPK promoter and a PGC1-α promoter as an active ingredient | 01-17-2013 |
20130045289 | COMPOSITION FOR PROMOTING THE ACTIVITY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA - Disclosed is a composition for promoting the activity of peroxisome proliferator-activated receptor-δ (PPAR-δ), which contains | 02-21-2013 |
20130090377 | COMPOSITION COMPRISING COUMESTROL OR A BEAN EXTRACT CONTAINING COUMESTROL - The present invention relates to a composition for activating mitochondria comprising coumestrol or a bean extract containing coumestrol. | 04-11-2013 |
Patent application number | Description | Published |
20130147526 | METHODS OF CONTROLLING CLOCKS IN SYSTEM ON CHIP INCLUDING FUNCTION BLOCKS, SYSTEMS ON CHIPS AND SEMICONDUCTOR SYSTEMS INCLUDING THE SAME - A system-on-chip includes a clock controller configured to decrease an operating frequency of at least one function block based on a change in an operating state of the at least one function block from an active state to an idle state. In a method of operating a system-on-chip including at least one function block, an operating frequency of the at least one function block is decreased based on a change in an operating state of the at least one function block from an active state to an idle state. The decreased operating frequency is greater than zero. | 06-13-2013 |
20130198545 | METHODS OF SPREADING PLURALITY OF INTERRUPTS, INTERRUPT REQUEST SIGNAL SPREADER CIRCUITS, AND SYSTEMS-ON-CHIPS HAVING THE SAME - In a method of power control for a system-on-chip, output of at least one of a first wakeup request signal and a second wakeup request signal is controlled such that a time interval between the output of the first wakeup request signal and the output of the second wakeup request signal is greater than or equal to a time interval threshold. The first wakeup request signal and the second wakeup request signal are one of concurrent and consecutive wakeup request signals. | 08-01-2013 |
20130318403 | Integrated Circuit Including Clock Controlled Debugging Circuit and System-on-Chip Including the Same - An integrated circuit includes a processor core, a clock control circuit and a debugging circuit. The processor core processes target software. The clock control circuit determines whether an electrical connection exists between the processor core and an external debugger and generates a determination result. The clock control circuit generates an output clock signal based on the determination result. The external debugger performs a debugging operation for the target software. The output clock signal is selectively activated based on the determination result and an input clock signal. The debugging circuit provides information with respect to the debugging operation for the target software to the external debugger based on the output clock signal. | 11-28-2013 |
20150084675 | METHODS OF CONTROLLING CLOCKS IN SYSTEM ON CHIP INCLUDING FUNCTION BLOCKS, SYSTEMS ON CHIPS AND SEMICONDUCTOR SYSTEMS INCLUDING THE SAME - A system-on-chip includes a clock controller configured to decrease an operating frequency of at least one function block based on a change in an operating state of the at least one function block from an active state to an idle state. In a method of operating a system-on-chip including at least one function block, an operating frequency of the at least one function block is decreased based on a change in an operating state of the at least one function block from an active state to an idle state. The decreased operating frequency is greater than zero. | 03-26-2015 |
Patent application number | Description | Published |
20130008421 | MAGAZINE RIFLE - Disclosed herein is a magazine rifle which includes a bullet loading mechanism and a firing mechanism interlinked to operate together by a single motor, thereby enabling single bullet firing, semi-automatic firing, and fully automatic firing. The magazine rifle includes a rotatable magazine, a bullet loading mechanism which loads a bullet received in the rotatable magazine into a cartridge chamber, and a firing mechanism which discharges compressed air from a compressed air cylinder according to manipulation of a trigger to allow the bullet loaded in the cartridge chamber to be fired through a barrel. The bullet loading mechanism and the firing mechanism are driven by a drive unit automatically driven by a single motor and a gear connected to the motor. | 01-10-2013 |
20130261825 | METHOD AND APPARATUS FOR CONTROLLING POWER SUPPLY - A demand response apparatus receives from a supply resource utilizing apparatus a signal indicating whether power supply from the demand response apparatus to the supply resource utilizing apparatus is possible, estimates a first power usage of the demand response apparatus for a first time interval, changes an operation of the demand response apparatus, estimates a second power usage for a second time interval after the changing of the operation of the demand response apparatus, calculates supply power available to the supply resource utilizing apparatus based on the estimated first power usage and the estimated second power usage, and transmits information about the available supply power to the supply resource utilizing apparatus. | 10-03-2013 |
20130261830 | APPARATUS AND METHOD FOR COLLECTING POWER FROM DISTRIBUTED POWER SUPPLY RESOURCES - An apparatus and method for collecting power from distributed power supply resources are provided. The method includes transmitting a signal for inquiring whether supply of demand-side power supply resources is possible to a providing side that provides demand-side power supply resources, selecting demand-side power supply resources to be utilized, based on power supply resource-related information for each of available demand-side power supply resources, which is received from the providing side, and notifying the selection results to the selected demand-side power supply resources. | 10-03-2013 |
20130261831 | ELECTRICITY STORAGE APPARATUS FOR CONTROLLING POWER CONSUMPTION AND METHOD THEREFOR - A method for controlling power consumption by an electricity storage apparatus is provided. The method includes receiving, from a utilizing side, an inquiry request signal for inquiring whether power supply from the electricity storage apparatus is possible, inquiring an amount of charged power from the electricity storage apparatus compared to a capacity of the electricity storage apparatus, comparing a required amount of power, which is included in the inquiry request signal, with the amount of charged power, and based on the comparison result, determining an amount of power to supply to the utilizing side and whether to switch to an operation mode of supplying the amount of power to the utilizing side, and upon determining to switch to the operation mode, checking an amount of available supply power in accordance with the operation mode, and transmitting information about the checked amount of available supply power to the utilizing side. | 10-03-2013 |
20140124834 | METHOD OF FABRICATING SEMICONDUCTOR DEVICE - A method of fabricating a semiconductor device is disclosed comprising the steps of: providing a substrate having a first region, a second region and a plurality of gate electrodes which are formed on the first and second regions of the substrate; forming a mask film to expose the first region of the substrate while covering the second region of the substrate, such that the mask film has a negative lateral profile at a boundary between the first and second regions of the substrate; forming sigma trenches in the first region of the substrate by etching the first region of the substrate using the mask film and the gate electrodes as a mask; and forming an epitaxial layer in each of the sigma trenches. | 05-08-2014 |
20140299840 | GRAPHENE LAMINATE WITH BAND GAP - A graphene laminate includes a first piezoelectric material layer having a negatively-charged surface and a positively-charged surface, a first graphene layer under the first piezoelectric material layer, the first graphene layer contacting the positively-charged surface of the first piezoelectric material layer, a second graphene layer underlying the first graphene layer, and a second piezoelectric material layer under the second graphene layer, the second piezoelectric material layer having a negatively-charged surface and a positively-charged surface, the negatively-charged surface contacting the second graphene layer. | 10-09-2014 |
Patent application number | Description | Published |
20160029970 | APPARATUS AND METHOD FOR DETERMINING VALIDITY OF BIOLOGICAL DATA - A method that includes acquiring a first biological data of a user from a measuring device and determining whether the acquired first biological data is within a valid data range, such that the valid data range includes at least one valid section, and a validity time period is set for each section of the at least one valid section. The method further includes transmitting the first biological data to a terminal when the acquired first biological data is within the valid data range. | 02-04-2016 |
20160088257 | MEDICAL CARE PROVIDER TERMINAL, PATIENT TERMINAL, AND VIDEO CALL METHOD THEREOF - Provided is a medical care provider terminal, a patient terminal and a method for making a video call therebetween. The method may include receiving, at a medical care provider terminal, a video call request from a patient terminal, connecting, at the medical care provider, a video call to the patient terminal, and displaying patient-related information in a first region of a display of the medical care provider terminal and displaying a video call screen in a second region of the display. The video call screen may include a sharing region for sharing with the patient terminal at least one of a first video captured by a camera module connected to the patient terminal, a second video captured by a camera module connected to the medical care provider terminal, the patient-related information, or data input at the medical care provider terminal. | 03-24-2016 |
Patent application number | Description | Published |
20150311572 | APPARATUS FOR CONTROLLING TEMPERATURE OF BATTERY - The present invention provides an apparatus for controlling the temperature of a battery, which is capable of cooling a battery such as a lithium ion battery and the like by using the circulation of a liquid refrigerant and controlling the temperature of the battery through an endothermic reaction or an exothermic reaction caused by a phase transformation process of the corresponding supersaturated liquid refrigerant. To this end, the present invention comprises: at least one temperature sensor for sensing the temperature of a battery pack so as to generate a temperature detection signal; a refrigerant pipe which is extended between arrangement spaces of a plurality of battery cells included in the battery pack and circulates the supersaturated liquid refrigerant through the inside thereof; a refrigerant circulation driving unit which drives a cooling operation by circulating the supersaturated liquid refrigerant through the refrigerant pipe when the temperature of the battery pack rises; and a control unit for driving and controlling the refrigerant circulation driving unit when the rise in the temperature of the battery pack is detected according to a temperature detection signal received from at least one temperature sensor. | 10-29-2015 |
20160123382 | EXTRUSION-TYPE CONNECTING ROD, EXTRUSION APPARATUS FOR CONNECTING ROD AND MANUFACTURING METHOD FOR EXTRUSION-TYPE CONNECTING ROD - The present invention relates to an extrusion-type connecting rod which is installed between a piston and a crank and can convert the reciprocating motion of the piston into the rotary motion of a crank shaft, an extrusion apparatus for a connecting rod, and a manufacturing method for the extrusion-type connecting rod. The extrusion-type connecting rod may comprise: a first big end having a portion of a crank shaft hole formed on one side and having a seam-line divided surface, which comprises a seam line formed at the time of extrusion, formed on the other side; a second big end, being extrusion-molded simultaneously with the first big end, having the other portion of the crank shaft hole formed on one side, and having a seam-line divided surface, which comprises a seam line formed at the time of extrusion, formed so as to contact the seam-line divided surface of the first big end; a connection part which is extrusion-molded integrally with the second big end; and a small end which is extrusion-molded integrally with the connection part. | 05-05-2016 |
Patent application number | Description | Published |
20130102028 | CARTILAGE-SPECIFIC HIF-2ALPHA TRANSGENIC MOUSE AS AN ANIMAL MODEL FOR ARTHRITIS, AND USE THEREOF - The present invention relates to a transgenic fertilized egg in which expression constructs, excluding human expression constructs, are introduced, including: (a) a nucleotide sequence encoding hypoxia-inducible factor 2α (HIF-2α); and (b) a transcription-regulating sequence which is operatively linked to the nucleotide sequence, as well as to a transgenic animal model for arthritis obtained therefrom. A transgenic mouse transformed with a recombinant expression vector of the present invention may be very useful as a therapeutic model for arthritis, which may be used in studies on the cartilage degeneration process. In addition, the transgenic mouse of the present invention may be applied to a method for screening arthritis therapeutics. | 04-25-2013 |
20130236531 | PHARMACEUTICAL COMPOSITION INCLUDING AN HIF-2 ALPHA INHIBITOR AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING ARTHRITIS - The present invention relates to a pharmaceutical composition for preventing or treating arthritis, including, as an active ingredient, a material which inhibits the expression of the hypoxia-inducible factor-2α (HIF-2α) gene or the activity of the HIF-2α protein. According to the present invention, the HIF-2α of the present invention increases the expression thereof in chondrocytes or tissue in which osteoarthritis is induced, and triggers the expression of various cartilage degeneration factors and the activation of mitogen-activated protein (MAP) kinase. In addition, when HIF-2α is inhibited, the expression level of cartilage degeneration factors and the phosphorylation of MAP kinase are significantly reduced by the inhibited degree of HIF-2α. Thus, the composition of the present invention may be applied to the prevention or treatment of arthritis, and may be used for the development of therapeutics for arthritis. | 09-12-2013 |
Patent application number | Description | Published |
20080261899 | AGENT FOR CONTROLLING Bcl-2 EXPRESSION COMPRISING GINSENOSIDE F1 AS AN ACTIVE COMPONENT - The present invention relates to an agent for controlling Bcl-2 expression comprising ginsenoside F1 (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) represented by the following formula 1 as an active component. | 10-23-2008 |
20080280838 | Composition Containing Ginsenoside F1 and Egcg for Preventing Skin Damage - The present invention relates to a skin-care composition containing ginsenoside F1 and EGCG. More particularly, the present invention relates to an inhibitor of UV-induced apoptosis in epidermal cells showing an excellent skin-care effect by the synergistic interaction of the said ginsenoside F1 and EGCG even at low concentrations, and to a method for inhibiting apoptosis in epidermal cells. | 11-13-2008 |
20090062217 | Promoter For The Production Of Hyaluronic Acid Containing Ginsenoside Compound K - There are provided a promoter containing ginsenoside compound K for the production of hyaluronic acid, and more particularly, a new efficacy of 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol (compound K), a chief metabolite of ginseng saponin, to increase the expression of hyaluronic acid synthase gene in human cell and thereby to promote the production of hyaluronic acid, and an anti-aging agent containing the promoter for the production of hyaluronic acid as an effective ingredient. | 03-05-2009 |
20140248381 | COMPOSITION FOR INHIBITING VASCULAR AGING COMPRISING SYRINGARESINOL - The present invention discloses a composition for inhibiting vascular aging comprising a compound of Chemical formula 1, a derivative thereof or a pharmaceutically acceptable salt thereof as an active ingredient. | 09-04-2014 |
20140371307 | SIRT 1 ACTIVATOR INCLUDING SYRINGARESINOL - The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases. | 12-18-2014 |
20150073158 | METHOD FOR PREPARING FUROFURAN LIGNAN COMPOUND - The present invention relates to a method for preparing a furofuran lignan compound, comprising a step of selecting and alkylating an epoxy alcohol compound and an optical isomer thereof. (+)-furofuran lignan and (−)-furofuran lignan, as well as an optical isomer thereof, can be selectively prepared by means of the method. | 03-12-2015 |
20150283110 | COMPOSITION FOR PREVENTING OR TREATING HEART DISEASE - The present invention relates to a composition for preventing or treating heart disease, and more particularly, to a composition for preventing or treating heart disease, comprising (+)-syringaresinol. Specifically, (+)-syringaresinol as an active ingredient may exhibit excellent effect of preventing or improving heart disease by promoting SIRT1 expression and suppressing death of cardiomyocytes induced by reactive oxygen species. Accordingly, the composition according to the present disclosure may be used to prevent, improve or treat heart diseases including cardiovascular diseases. | 10-08-2015 |
20150290105 | COMPOSITION COMPRISING SYRINGARESINOL FOR IMPROVING THE SKIN - The present invention relates to a composition for improving the skin, which comprises the compound of chemical formula 1, the derivatives thereof, or the pharmaceutically acceptable salts thereof as active ingredients. | 10-15-2015 |
Patent application number | Description | Published |
20130175494 | MEMORY CELLS INCLUDING TOP ELECTRODES COMPRISING METAL SILICIDE, APPARATUSES INCLUDING SUCH CELLS, AND RELATED METHODS - Memory cells (e.g., CBRAM cells) include an ion source material over an active material and an electrode comprising metal silicide over the ion source material. The ion source material may include at least one of a chalcogenide material and a metal. Apparatuses, such as systems and devices, include a plurality of such memory cells. Memory cells include an adhesion material of metal silicide between a ion source material and an electrode of elemental metal. Methods of forming a memory cell include forming a first electrode, forming an active material, forming an ion source material, and forming a second electrode including metal silicide over the metal ion source material. Methods of adhering a material including copper and a material including tungsten include forming a tungsten silicide material over a material including copper and treating the materials. | 07-11-2013 |
20150295171 | MEMORY CELLS AND SEMICONDUCTOR STRUCTURES INCLUDING ELECTRODES COMPRISING A METAL, AND RELATED METHODS - Memory cells (e.g., CBRAM cells) include an ion source material over an active material and an electrode comprising metal silicide over the ion source material. The ion source material may include at least one of a chalcogenide material and a metal. Apparatuses, such as systems and devices, include a plurality of such memory cells. Memory cells include an adhesion material of metal silicide between a ion source material and an electrode of elemental metal. Methods of forming a memory cell include forming a first electrode, forming an active material, forming an ion source material, and forming a second electrode including metal silicide over the metal ion source material. Methods of adhering a material including copper and a material including tungsten include forming a tungsten silicide material over a material including copper and treating the materials. | 10-15-2015 |
Patent application number | Description | Published |
20090188000 | GENE FAMILY (LBFL313) ASSOCIATED WITH PANCREATIC CANCER - The invention relates generally to the changes in gene expression in human pancreatic adenocarcinoma. The invention relates specifically to a human gene family which is differentially expressed in cancerous pancreatic tissues compared to corresponding non-cancerous pancreatic tissues. | 07-23-2009 |
20110137202 | BIOPSY NEEDLE DEVICE - A biopsy needle device for collecting a tissue sample by penetrating a living body includes a needle. The needle includes a tip portion having a cross-sectional area getting gradually smaller toward a front end thereof and a tissue container portion arranged behind the tip portion for holding the tissue sample therein. The tip portion includes a rear surface contiguous to the tissue container portion and a recess formed on the rear surface. | 06-09-2011 |
20130059751 | GENE FAMILY (LBFL313) ASSOCIATED WITH PANCREATIC CANCER - The invention relates generally to the changes in gene expression in human pancreatic adenocarcinoma. The invention relates specifically to a human gene family which is differentially expressed in cancerous pancreatic tissues compared to corresponding non-cancerous pancreatic tissues. | 03-07-2013 |
20140018304 | METHOD FOR SCREENING FOR A CANCER TREATMENT AGENT USING THE INTERACTION BETWEEN PAUF AND A BINDING PARTNER THEREOF - The present invention relates to a method for screening for a cancer treatment agent by contacting a test material with pancreatic adenocarcinoma upregulated factor (PAUF) and GLRX3, SNAPIN, or UBL4A, as a binding partner for PAUF, and then analyzing whether or not the test material inhibits the binding of the PAUF and GLRX3, SNAPIN, or UBL4A serving as a binding partner therefor, thereby determining that the test material is a cancer treatment agent if the binding is inhibited. The invention also relates to a pharmaceutical composition containing the test material as an active ingredient for inhibiting and treating cancer. The pharmaceutical composition of the present invention, which contains, as an active ingredient, an inhibitor for inhibiting PAUF from binding with a binding partner, effectively inhibits PAUF signaling related to the onset of cancer, thus enabling various kinds of cancer (especially pancreatic cancer) to be treated. | 01-16-2014 |
20140039033 | NOVEL PANCREATIC CANCER BIOMARKER USING THE CHARACTERISTICS OF PANCREATIC CANCER STEM CELLS, AND USE THEREOF - The present invention relates to a novel molecular marker for pancreatic cancer stem cells and pancreatic cancer, to a marker detection method, and to a screening method. The present invention is a marker discovered from the cell lines of pancreatic cancer, wherein the marker may detect pancreatic cancer, in particular early pancreatic cancer, through the detection of a pancreatic cancer stem cell marker. In addition, the marker of the present invention may enable an accurate diagnosis and prognosis analysis of pancreatic cancer. | 02-06-2014 |